SteelPeak Wealth LLC bought a new position in shares of Universal Health Services, Inc. (NYSE:UHS – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 3,675 shares of the health services provider’s stock, valued at approximately $659,000.
Several other hedge funds and other institutional investors have also modified their holdings of UHS. Cerity Partners LLC raised its holdings in Universal Health Services by 86.4% in the 3rd quarter. Cerity Partners LLC now owns 21,047 shares of the health services provider’s stock valued at $4,820,000 after acquiring an additional 9,755 shares during the period. JPMorgan Chase & Co. lifted its holdings in Universal Health Services by 0.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,197,537 shares of the health services provider’s stock worth $274,248,000 after purchasing an additional 10,578 shares during the last quarter. Vestcor Inc lifted its holdings in Universal Health Services by 1,436.5% during the 3rd quarter. Vestcor Inc now owns 54,070 shares of the health services provider’s stock worth $12,383,000 after purchasing an additional 50,551 shares during the last quarter. Geode Capital Management LLC boosted its stake in Universal Health Services by 4.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,661,530 shares of the health services provider’s stock valued at $379,403,000 after purchasing an additional 63,754 shares during the period. Finally, Eagle Asset Management Inc. acquired a new position in Universal Health Services in the 3rd quarter valued at $13,496,000. Institutional investors own 86.05% of the company’s stock.
Universal Health Services Price Performance
Shares of NYSE:UHS opened at $189.24 on Friday. Universal Health Services, Inc. has a one year low of $152.68 and a one year high of $243.25. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.39 and a quick ratio of 1.28. The company has a market cap of $12.48 billion, a price-to-earnings ratio of 12.58, a PEG ratio of 0.54 and a beta of 1.30. The firm has a 50 day simple moving average of $187.97 and a 200 day simple moving average of $207.56.
Universal Health Services Dividend Announcement
Insider Buying and Selling
In related news, Director Maria Ruderman Singer sold 1,614 shares of Universal Health Services stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $191.15, for a total transaction of $308,516.10. Following the sale, the director now directly owns 5,879 shares in the company, valued at $1,123,770.85. This trade represents a 21.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 16.10% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on UHS. KeyCorp began coverage on shares of Universal Health Services in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. The Goldman Sachs Group lowered shares of Universal Health Services from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $228.00 to $198.00 in a research report on Monday, December 16th. Bank of America initiated coverage on shares of Universal Health Services in a research report on Wednesday, November 6th. They issued a “neutral” rating and a $223.00 price target for the company. Barclays increased their price target on Universal Health Services from $256.00 to $271.00 and gave the stock an “overweight” rating in a research report on Friday, October 25th. Finally, StockNews.com cut Universal Health Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 9th. Seven research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $226.14.
Check Out Our Latest Report on Universal Health Services
Universal Health Services Company Profile
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Further Reading
- Five stocks we like better than Universal Health Services
- What Are Dividend Challengers?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- The 3 Best Blue-Chip Stocks to Buy Now
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is the S&P 500 and How It is Distinct from Other Indexes
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS – Free Report).
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.